The autoimmune basis of alopecia areata: a comprehensive review.
📑 인용한 논문 (6) ▾
- Responses to Tetanus and Meningococcal Vaccines in Patients with Alopecia Areata Treated w… Dermatology and therapy · 2026
- Dermatologists' Perspectives and Real-World Assessment of Alopecia Areata Severity in Adul… Dermatology and therapy · 2026
- Long-Term Efficacy and Safety of Ritlecitinib in Adults and Adolescents with Alopecia Area… American journal of clinical dermatology · 2026
- Is Spontaneous Regrowth in Alopecia Areata Possible: A Systematic Review and Meta-analysis… Acta dermato-venereologica · 2025
- LncRNA NEAT1 and miRNA 101 as potential diagnostic biomarkers in patients with alopecia ar… Non-coding RNA research · 2025
- Evaluation of Olive Oil-Based Formulations Loaded with Baricitinib for Topical Treatment o… Pharmaceutics · 2025
Abstract 🌐 Abstract
Recent studies suggest that intervention of the JAK pathway may have a potential therapeutic efficacy for AA, and multiple treatment options including the use of broad acting corticosteroids appear to
추출된 의학 개체 (NER)
전체 NER 표 보기
| 유형 | 영어 표현 | 한국어 / 풀이 | UMLS CUI | 출처 | 등장 |
|---|---|---|---|---|---|
| 해부 | scalp
|
두피 | dict | 3 | |
| 해부 | scalp
|
두피 | dict | 3 | |
| 해부 | scalp
|
두피 | dict | 3 | |
| 질환 | alopecia areata
|
원형 탈모증 | dict | 2 | |
| 질환 | alopecia areata
|
원형 탈모증 | dict | 2 | |
| 질환 | alopecia areata
|
원형 탈모증 | dict | 2 |
🏷️ 키워드 / MeSH 📖 같은 키워드 OA만
인용 관계
이 논문을 인용한 후속 연구 20
- Epidemiology and burden of alopecia areata: a systematic review.
- "'You lose your hair, what's the big deal?' I was so embarrassed, I was so self-conscious, I was so …
- The Role of Micronutrients in Alopecia Areata: A Review.
- Alopecia areata: Animal models illuminate autoimmune pathogenesis and novel immunotherapeutic strate…
- Complementary and Alternative Treatments for Alopecia: A Comprehensive Review.
- Alopecia Areata Treatment Patterns, Healthcare Resource Utilization, and Comorbidities in the US Pop…
- Drug discovery for alopecia: gone today, hair tomorrow.
- The Invisible Impact of a Visible Disease: Psychosocial Impact of Alopecia Areata.
- Utilization of Mental Health Resources and Complementary and Alternative Therapies for Alopecia Area…
- Prevalence and Risk Factors Associated with the Occurrence of Autoimmune Diseases in Patients with A…
- Understanding autoimmunity of vitiligo and alopecia areata.
- Integrated Safety Analysis of Ritlecitinib, an Oral JAK3/TEC Family Kinase Inhibitor, for the Treatm…
- Development of the Scalp Hair Assessment PRO™ measure for alopecia areata.
- Serum Vitamin D in patients with alopecia areata.
- Integrated single-cell chromatin and transcriptomic analyses of human scalp identify gene-regulatory…
- Cumulative Life Course Impairment of Alopecia Areata.
- Whole exome sequencing in Alopecia Areata identifies rare variants in KRT82.
- Treatments for alopecia areata: a network meta-analysis.
- Patient characteristics and disease burden of alopecia areata in the Danish Skin Cohort.
- Altered expression of intracellular Toll-like receptors in peripheral blood mononuclear cells from p…
같은 제1저자의 인용 많은 논문 (4)
- Adipose and Hair Function: An aPPARent Connection.
- Single nucleotide polymorphisms affecting galantamine binding to acetylcholinesterase in Alzheimer's disease: a structural bioinformatics study.
- Development of a Dynamic Counterfactual Risk Stratification Strategy for Newly Diagnosed Patients With AML Treated With Venetoclax and Azacitidine.
- Investigating molecular background of multiple sclerosis through multi-omics: linking via psychoneuroimmunology.
🏷️ 같은 키워드 · 무료전문 — 이 논문 MeSH/keyword 기반
📖 비슷한 OA 논문 — 같은 카테고리, 무료 전문 가능
-
Alopecia areata.
TL;DRAlopecia areata is difficult to manage medically, but recent advances in understanding the molecular mechanisms have revealed new treatments and the possibility of remission in the…
-
Epidemiology and burden of alopecia areata: a systematic review.
TL;DRAA is the most prevalent autoimmune disorder and the second most prevalent hair loss disorder after androgenetic alopecia, and the lifetime risk in the global population is approxi…
-
Two Phase 3 Trials of Baricitinib for Alopecia Areata.
TL;DRIn two phase 3 trials involving patients with severe alopecia areata, oral baricitinib was superior to placebo with respect to hair regrowth at 36 weeks.
-
Treatment options for androgenetic alopecia: Efficacy, side effects, compliance, financial considerations, and ethics.
TL;DRAlthough a variety of medical, surgical, light‐based and nutraceutical treatment options are available to slow or reverse the progression of AGA, it can be challenging to select ap…
-
Hair follicle immune privilege and its collapse in alopecia areata.
TL;DRA key goal for effective AA management is the re‐establishment of a functional HF IP, which will also provide superior protection from disease relapse, and may confer increased sus…